drugset / Trial / NCT02312375

Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients

NCT02312375

Completed 46 enrolled Seoul National University Hospital
RandomizedCrossoverOpen-labelTreatment

Summary

This study was designed to evaluate the effect of ARB in improving insulin secretion in patients with type 2 diabetes. The investigators also aimed to evaluate if there are potential synergisms between ARB and DPP4 inhibitors in improving insulin secretion and urinary albumin secretion in diabetic patients.

Timeline

Start
2015-03
Primary completion
2016-12
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified
Subject Fimasartan Small molecule